Propel Bio Management’s Trevi Therapeutics TRVI Stock Holding History

Propel Bio Management’s Portfolio TRVI Stock Details TRVI Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.65M	Buy
2024 Q3	–	Sell
2024 Q2	$775K	Hold
2024 Q1	$897K	Buy